tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

AZN Stock Latest News

AstraZeneca says Enhertu plus pertuzumab approved by FDA for 1st line treatment
The FlyAstraZeneca says Enhertu plus pertuzumab approved by FDA for 1st line treatment
2h ago
AZN
AstraZeneca confirms FDA approves Enhertu combo for certain breast cancers
PremiumThe Fly
AstraZeneca confirms FDA approves Enhertu combo for certain breast cancers
3h ago
AZN
FDA approves Enhertu with pertuzumab for certain HER2-positive breast cancer
PremiumThe Fly
FDA approves Enhertu with pertuzumab for certain HER2-positive breast cancer
5h ago
AZN
AstraZeneca’s Latest Study on AZD1613: A Potential Breakthrough for Kidney Disease
PremiumCompany Announcements
AstraZeneca’s Latest Study on AZD1613: A Potential Breakthrough for Kidney Disease
1d ago
AZN
AstraZeneca’s AZD4604: Promising Results in Asthma Treatment Study
PremiumCompany Announcements
AstraZeneca’s AZD4604: Promising Results in Asthma Treatment Study
1d ago
AZN
AstraZeneca’s AZD4076: Promising Developments in NASH Treatment
PremiumCompany AnnouncementsAstraZeneca’s AZD4076: Promising Developments in NASH Treatment
1d ago
AZN
AstraZeneca’s Acalabrutinib Study: A Potential Game-Changer for CLL Treatment
Premium
Company Announcements
AstraZeneca’s Acalabrutinib Study: A Potential Game-Changer for CLL Treatment
1d ago
AZN
AstraZeneca’s AZD4144 Study: A New Hope for Cardiovascular and Kidney Disease?
Premium
Company Announcements
AstraZeneca’s AZD4144 Study: A New Hope for Cardiovascular and Kidney Disease?
1d ago
AZN
AstraZeneca’s Tozorakimab Study: A Step Forward in Drug Delivery
PremiumCompany Announcements
AstraZeneca’s Tozorakimab Study: A Step Forward in Drug Delivery
1d ago
AZN
3 Best Japanese Stocks to Invest In, According to AI Analyst
PremiumMarket News
3 Best Japanese Stocks to Invest In, According to AI Analyst
5d ago
GS
AZN
AstraZeneca price target raised to $108 from $95 at HSBC
PremiumThe Fly
AstraZeneca price target raised to $108 from $95 at HSBC
5d ago
AZN
AstraZeneca price target raised to $105 from $95 at TD Cowen
PremiumThe Fly
AstraZeneca price target raised to $105 from $95 at TD Cowen
6d ago
AZN
AstraZeneca, Daiichi Sankyo dose first patient in DESTINY-Ovarian01 trial
PremiumThe FlyAstraZeneca, Daiichi Sankyo dose first patient in DESTINY-Ovarian01 trial
6d ago
AZN
AstraZeneca price target raised to 16,000 GBp from 14,000 GBp at JPMorgan
Premium
The Fly
AstraZeneca price target raised to 16,000 GBp from 14,000 GBp at JPMorgan
7d ago
AZN
JPMorgan ups AstraZeneca target, adds to Analyst Focus List
Premium
The Fly
JPMorgan ups AstraZeneca target, adds to Analyst Focus List
8d ago
AZN
Trump Weekly: President approves U.S. manufacturing of ‘tiny cars’
PremiumThe Fly
Trump Weekly: President approves U.S. manufacturing of ‘tiny cars’
10d ago
F
GM
Salesforce (CRM) Wins AstraZeneca Deal, Becomes the Unified Global Platform
PremiumMarket News
Salesforce (CRM) Wins AstraZeneca Deal, Becomes the Unified Global Platform
11d ago
AZN
CRM
Salesforce’s Agentforce selected by AstraZeneca as unified global platform
PremiumThe Fly
Salesforce’s Agentforce selected by AstraZeneca as unified global platform
11d ago
AZN
CRM
AstraZeneca Stake Adjustment by Capital Group
PremiumCompany Announcements
AstraZeneca Stake Adjustment by Capital Group
11d ago
6K
AZN
FDA shift in drug study requirements sends trial runners lower
PremiumThe FlyFDA shift in drug study requirements sends trial runners lower
11d ago
AZN
BMY
FDA to reduce number of trials required for drug approvals, STAT reports
Premium
The Fly
FDA to reduce number of trials required for drug approvals, STAT reports
11d ago
AZN
BMY
FDA to reduce number of trials required for drug approvals, STAT reports
Premium
The Fly
FDA to reduce number of trials required for drug approvals, STAT reports
11d ago
AZN
BMY

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >